Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.

Health technology assessment (Winchester, England)（2022）

引用 0|浏览16

暂无评分

摘要

This project was funded by the National Institute for Health and Care Research ( NIHR ) Health Technology Assessment programme and will be published in full in ; Vol. 26, No. 50. See the NIHR Journals Library website for further project information.

查看译文

关键词

AFLIBERCEPT,ANTI-VEGFS,BEVACIZUMAB,COST-EFFECTIVENESS,DIABETES,DIABETIC MACULAR EDEMA,DIABETIC MACULAR OEDEMA,DME,DMO,EQ5D,EQ5D-5L,LASER,MICROPULSE,NEI VFQ25,PHOTOCOAGULATION,QOL,QUALITY OF LIFE,RANDOMISED CLINICAL TRIAL,RANIBIZUMAB,RCT,STEROIDS,SUBTHRESHOLD LASER,VASCULAR ENDOTHELIAL GROWTH FACTOR,VEGF,VISQOL

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要